Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.700 | strong | 1.000 | 15 | 1 | 1989 | 2019 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.500 | None | 0.983 | 221 | 17 | 1983 | 2020 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.582 | 0.500 | 7.2E-08 |
|
disease | 0.500 | None | 1.000 | 10 | 2 | 1994 | 2016 | ||||||||
|
cytochrome p450 oxidoreductase | 0.502 | 0.769 | 3.4E-10 |
|
disease | 0.460 | None | 0.857 | 5 | 1 | 2004 | 2016 | ||||||||
|
phosphodiesterase 8B | 0.638 | 0.500 | 1.00 |
|
disease | 0.420 | None | 1.000 | 2 | 0 | 2008 | 2010 | ||||||||
|
cytochrome P450 family 11 subfamily B member 1 | 0.563 | 0.615 | 8.2E-07 |
|
disease | 0.200 | None | 1.000 | 36 | 3 | 1991 | 2018 | ||||||||
|
steroidogenic acute regulatory protein | 0.513 | 0.808 | 8.8E-11 |
|
disease | 0.140 | None | 1.000 | 4 | 0 | 2011 | 2019 | ||||||||
|
cytochrome P450 family 11 subfamily B member 2 | 0.553 | 0.615 | 7.1E-19 |
|
disease | 0.130 | None | 1.000 | 3 | 1 | 2001 | 2004 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 5 | 0.560 | 0.577 | 3.4E-04 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2012 | 2015 | ||||||||
|
phosphodiesterase 11A | 0.612 | 0.654 | 8.7E-37 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2009 | 2010 | ||||||||
|
protein kinase cAMP-activated catalytic subunit alpha | 0.606 | 0.692 | 0.97 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2015 | 2015 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.100 | None | 1.000 | 31 | 1 | 1977 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
disease | 0.100 | None | 1.000 | 18 | 1 | 1986 | 2019 | ||||||||
|
cytochrome P450 family 21 subfamily A member 1, pseudogene | 0.780 | 0.500 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1990 | 2013 | |||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 6 | 2005 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 1992 | 2017 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 0.619 | 0.462 | 2.4E-07 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2000 | 2005 | ||||||||
|
glyoxalase I | 0.537 | 0.769 | 9.7E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1982 | 1987 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1980 | 2016 | ||||||||
|
carbohydrate sulfotransferase 3 | 0.517 | 0.846 | 7.2E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2002 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
tenascin XA (pseudogene) | 0.821 | 0.269 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2015 | |||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2020 | ||||||||
|
sex determining region Y | 0.456 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1992 | 2014 | |||||||||
|
melanocortin 2 receptor | 0.582 | 0.654 | 3.1E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2014 |